Cost-effectiveness analysis of pembrolizumab plus...

Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA

Zeng, Xiaohui, Wan, Xiaomin, Peng, Liubao, Peng, Ye, Ma, Fang, Liu, Qiao, Tan, Chongqing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-031019
Date:
December, 2019
File:
PDF, 397 KB
2019
Conversion to is in progress
Conversion to is failed